A Double-blind, Randomized, Placebo-controlled Trial Evaluating The Safety And Efficacy Of Early Treatment With Eplerenone In Patients With Acute Myocardial Infarction
A Double-blind, Randomized, Placebo-controlled Trial Evaluating The Safety And Efficacy Of Early Treatment With Eplerenone In Patients With Acute Myocardial Infarction
Administration of eplerenone within 24 hours of onset of symptoms of myocardial infarction, in patients without heart failure, reduces cardiovascular mortality / morbidity.
Inclusion Criteria:
Exclusion Criteria:
Vancouver, British Columbia V5Z 1M9, Canada
Chicoutimi, Quebec G7H 5H6, Canada
Sherbrooke, Quebec J1H 5N4, Canada
Göttingen, 37075, Germany
Rio Patra, 26500, Greece
Nyíregyháza, 4400, Hungary
Oświęcim, 32-600, Poland
Blackpool, Lancashire FY3 8NR, United Kingdom
Cottingham Hull, HU16 5JQ, United Kingdom